Tuesday, June 18, 2019 8:45:41 PM
Evidence of the cheap herbicide’s danger to biological functions and the environment continues to mount. Why are U.S. regulators not listening?
By Mark Buchanan
June 4, 2019, 11:30 AM EDT
Corrected June 5, 2019, 3:36 PM EDT
Is it worth it?
Is it worth it? Photographer: Daniel Acker/Bloomberg
Chemicals giant Bayer AG is reeling after a jury awarded $2 billion in damages to people who say they contracted cancer after years of using Roundup, a popular weed killer manufactured by Bayer subsidiary Monsanto Co. Bayer probably won't pay out the full $2 billion. But more than 10,000 further cases are pending, worrying Bayer investors as well as farmers who rely on the product as a cheap, effective herbicide.
Cancer may only be part of the story. Studies over the past decade suggest that glyphosate — the active ingredient in Roundup — pollutes water sources, hangs around in soil far longer than previously suspected, and routinely taints human food supplies. In both the U.S. and Europe, the supposedly safe limits for human ingestion are based on long-outdated science. Research also points to serious adverse consequences for the environment, and there are indications glyphosate can cause disease in mammals even several generations removed from the initial exposure.
Glyphosate isn't as safe as its manufacturers would like us to believe, and steep reduction in its use is probably long overdue.
Monsanto patented glyphosate in the early 1970s, and it rapidly became the global go-to chemical for weed control as the commercial product Roundup. Executives at Monsanto encouraged the spread of Roundup by engineering genetically modified seeds for corn and other crops that can tolerate glyphosate.
Glyphosate manufacturers — which now include many companies around the world; Monsanto's patent expired in 2000 — have long argued that glyphosate is completely safe for humans, animals and indeed all non-plant life. It works by inhibiting a biochemical pathway that plants need to grow, and animals don't share that pathway, which is superficially reassuring. But it only means that glyphosate shouldn't starve animals to death, as it does plants. Chemicals can exert effects on organisms in myriad ways.
Interpreting the evidence for cancer isn't easy, because different panels have come to contrasting conclusions by using different procedures. In 2015, the International Agency for Research on Cancer, part of the World Health Organization, concluded that glyphosate is likely carcinogenic. But both the U.S. Environmental Protection Agency and the European Food Safety Authority have declined to do the same. Both the EPA and the EFSA relied on information provided by researchers linked to the industry and considered studies provided by the industry that were not peer-reviewed or made public. The IARC relied solely on publicly available peer-reviewed research.
An international team of biologists reviewed the IARC and EFSA studies, concluding that the latter were significantly flawed and departed from standard hazard-assessment practices.
There are plenty of other reasons to be concerned about glyphosate. An independent group of biologists in 2016 tried to clarify what we really know about the chemical. Their paper makes for grim reading. It noted that studies in the previous decade found significant traces of glyphosate-based herbicides in drinking water and groundwater, probably routinely exposing millions of people across the planet to the chemical. Toxicity studies in rodents have found that glyphosate can damage the liver and kidneys, even for doses in the range generally considered safe for humans. Young pigs fed soybeans contaminated with glyphosate herbicide residues have exhibited congenital malformations, not unlike birth defects observed for people living in and near farming regions with intensive glyphosate use.
The study points to many other troubling findings, from the disruptive impact of glyphosate on hormone signaling in mammals to how the chemical binds to metals such as zinc, cobalt and manganese, reducing the supplies of these crucial micronutrients for people, crops and other plants, and wildlife. Most of these effects would probably not be detected by the traditional toxicology test guidelines currently favored by pesticide regulators.
In April, a different study found another worrying effect: Glyphosate might disrupt biological functions for generations. One of the hottest topics in biology in recent years has been epigenetics — the study of how offspring inherit not only the genes of their parents, but also certain patterns of chemical activity written onto those genes by other signaling molecules. This offers a means by which environmental factors that affect an organism during its life can be passed down to its offspring. In experiments with rats fed glyphosate, Michael Skinner of Washington State University and colleagues found that malign effects of treatment did not show up in the organism eating glyphosate, or even in its offspring, but in the next two generations of offspring. These rats, without ever being exposed to glyphosate, nevertheless showed a prominent tendency toward prostate disease, obesity, kidney disease, ovarian disease and birth abnormalities.
Glyphosate is clearly not a benign herbicide warranting no concern, its link to cancer aside. It may be causing many other serious disruptions to human biology, and to organisms and plants in the environment, currently invisible to today's outdated regulatory systems. It's about time our regulators updated their science.
Recent BAYRY News
- Bayer Names Nelson Ambrogio as New Head of Radiology Business • Dow Jones News • 01/22/2024 02:26:00 PM
- Bayer's Menopause Drug Elinzanetant Met Primary Endpoints in Phase 3 Studies • Dow Jones News • 01/08/2024 08:05:00 AM
- Bayer's Monsanto Ordered to Pay $857 Million Over Chemicals in Washington State School, Bloomberg Reports • Dow Jones News • 12/19/2023 10:12:00 AM
- Trending: Bayer Shares Tank After Key Clinical Trial Halted Early, Roundup Verdict • Dow Jones News • 11/20/2023 03:43:00 PM
- Bayer Shares Tumble After Clinical Trial Failure, Roundup Case Loss • Dow Jones News • 11/20/2023 10:20:00 AM
- Bayer Stops Late-Stage Study for Stroke Prevention Due to Lack of Efficacy • Dow Jones News • 11/20/2023 07:22:00 AM
- Bayer Pulling Lymphoma Drug Aliqopa From U.S. • Dow Jones News • 11/13/2023 03:58:00 PM
- Bayer Gets CHMP Backing for Higher-Dose Eylea in Two Major Retinal Eye Diseases • Dow Jones News • 11/10/2023 03:00:00 PM
- Bayer Weighs Structural Changes But Rules Out Three-Way Split -- 3rd Update • Dow Jones News • 11/08/2023 10:32:00 AM
- Bayer Weighs Structural Changes But Rules Out Three-Way Split -- 2nd Update • Dow Jones News • 11/08/2023 08:40:00 AM
- Bayer Considers Structural Changes But Rules Out Three-Way Split -- Update • Dow Jones News • 11/08/2023 07:41:00 AM
- Bayer Looks at Options to Overhaul Structure • Dow Jones News • 11/08/2023 07:17:00 AM
- Bayer Launches New Rice Cultivation Method it Says Can Cut Emissions by 45% -- OPIS • Dow Jones News • 10/16/2023 10:03:00 PM
- Bayer to Cut Management Jobs Ahead of Restructuring, Reuters Reports • Dow Jones News • 09/15/2023 07:27:00 AM
- Bayer, Pairwise Seal Partnership on Short-Stature Corn • Dow Jones News • 08/29/2023 12:46:00 PM
- Artisan Partners Calls on Bayer to 'De-Merge' -- Reuters • Dow Jones News • 08/25/2023 05:42:00 PM
- Bayer to Unveil Strategy in Early 2024; Doesn't Rule out Structural Changes • Dow Jones News • 08/08/2023 02:28:00 PM
- Bayer Hit by Around $2.5 Billion of Impairments at Ailing Crop Business • Dow Jones News • 08/08/2023 06:43:00 AM
- Bayer Group Lowers 2023 Outlook on Declining Sales of Herbicides • Dow Jones News • 07/24/2023 06:45:00 PM
- Bayer's Mammography Screening Injection Approved by FDA • Dow Jones News • 06/23/2023 06:36:00 PM
- Bayer Appoints New Head of U.S. Operations • Dow Jones News • 06/21/2023 02:53:00 PM
- Bayer Shares Fall on Worse-Than-Expected 1Q • Dow Jones News • 05/11/2023 08:37:00 AM
- Bayer 1Q Earnings Hurt by Glyphosate Business, Inflation • Dow Jones News • 05/11/2023 06:30:00 AM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM
Avant Technologies Launches Advanced AI Supercomputing Network and Expansive Data Solutions • AVAI • Apr 23, 2024 8:00 AM
BestGrowthStocks.com Issues Comprehensive Analysis of Triller Merger with AGBA Group Holding Limited • AGBA • Apr 22, 2024 1:00 PM
Cannabix Technologies to Present Marijuana Breathalyzer Technology at International Association for Chemical Testing (IACT) Conference in California • BLO • Apr 22, 2024 8:49 AM
Kona Gold Beverages, Inc. Prepares for First Production Run Set to Launch May 17, 2024 • KGKG • Apr 22, 2024 8:30 AM